Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Steven C. Griffen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde, DEPICT-1 Investigators

Research output: Contribution to journalArticlepeer-review

223 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences